Sciencast Management LP lessened its holdings in Agilent Technologies Inc (NYSE:A) by 11.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,160 shares of the medical research company’s stock after selling 1,988 shares during the quarter. Sciencast Management LP’s holdings in Agilent Technologies were worth $1,106,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Compagnie Lombard Odier SCmA purchased a new stake in shares of Agilent Technologies in the fourth quarter worth $126,000. Point72 Asia Hong Kong Ltd grew its stake in Agilent Technologies by 303.2% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,859 shares of the medical research company’s stock valued at $191,000 after acquiring an additional 2,150 shares in the last quarter. AMG National Trust Bank purchased a new position in Agilent Technologies during the fourth quarter valued at $201,000. Signaturefd LLC bought a new stake in shares of Agilent Technologies in the 1st quarter worth about $201,000. Finally, Premia Global Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth about $204,000.
A number of equities research analysts recently weighed in on A shares. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Monday, March 26th. Morgan Stanley boosted their target price on shares of Agilent Technologies from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Monday, April 2nd. Goldman Sachs Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a research note on Monday, April 9th. Finally, Cowen upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a research note on Tuesday, May 15th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $72.75.
Shares of NYSE:A opened at $61.84 on Friday. The company has a market capitalization of $19.61 billion, a P/E ratio of 26.20, a PEG ratio of 2.14 and a beta of 1.28. Agilent Technologies Inc has a fifty-two week low of $58.22 and a fifty-two week high of $75.00. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.88 and a current ratio of 3.32.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.64 by $0.01. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.58 earnings per share. analysts predict that Agilent Technologies Inc will post 2.67 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 25th. Investors of record on Tuesday, July 3rd will be given a $0.149 dividend. The ex-dividend date is Monday, July 2nd. This represents a $0.60 dividend on an annualized basis and a yield of 0.96%. Agilent Technologies’s dividend payout ratio (DPR) is 25.42%.
In other news, Director Boon Hwee Koh sold 6,931 shares of Agilent Technologies stock in a transaction on Tuesday, June 12th. The stock was sold at an average price of $66.38, for a total transaction of $460,079.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.